South Asian Association for Regional Cooperation (SAARC) and Brazil, Russia, India, China, and South Africa (BRICS) countries' contribution in the field of science and engineering has grown immensely over the decade. BRICS countries have accelerated their efforts in healthcare, as well in the pharmaceutical sector through increased efforts in research and development, acquisitions, and generic drug manufacturing. Pharmacoeconomics and health outcomes research field give an indication about healthcare coverage and access decisions. India being significantly major player among SAARC and BRICS countries in terms of economy and policy making, the present study attempted to analyze scientific research presentation made by India compared to SAARC and BRICS countries in the area of pharmacoeconomics and health outcomes research at International Society for Pharmacoeconomics and Outcomes Research Meetings. The scientific research presentation abstracts published from 2008 to 2017 were included in the study. Research in the area of pharmacoeconomics and health outcomes studies has increased in SAARC and BRICS countries over the last 10 years. The collaborative research with foreign/international authors is also increasing, which is an encouraging trend in this area. The research carried out by SAARC and BRICS countries in the above-said area should be strengthened further which may be beneficial to the society in the coming years.
All Science Journal Classification (ASJC) codes
- Medicine (miscellaneous)
- Pharmacology, Toxicology and Pharmaceutics(all)
- Pharmacology (medical)